By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Keryx Biopharmaceuticals 

750 Lexington Avenue, 26th Floor

New York  New York  10022  U.S.A.
Phone: 212-531-5965 Fax: 212-531-5961



Company News
Keryx (KERX) Announces Second Quarter 2015 Financial Results 8/5/2015 2:03:43 PM
Keryx (KERX) Appoints Scott A. Holmes As Chief Financial Officer 7/27/2015 7:39:24 AM
Keryx (KERX) Receives CHMP Positive Opinion For Fexeric (Ferric Citrate Coordination Complex) For The Treatment Of Hyperphosphatemia In Adults With Chronic Kidney Disease 7/24/2015 7:24:37 AM
Keryx (KERX) Announces Two National Insurance Providers Added Auryxia To Their Medicare Part D Formularies 6/24/2015 11:59:09 AM
Keryx (KERX) To Present At The JMP Securities Life Sciences Conference 2015 6/16/2015 10:53:39 AM
A Battle is Brewing Between Keryx (KERX)'s Largest Backer and Short Investors 5/13/2015 6:24:33 AM
Keryx (KERX) Transitions to Boston Pharma Hub, Prepares Hiring Expansion 5/8/2015 5:58:26 AM
Keryx (KERX) To Present A Bank of America (BAC) Merrill Lynch 2015 Health Care Conference 5/6/2015 1:31:33 PM
Keryx Biopharmaceuticals (KERX) Announces First Quarter 2015 Financial Results 5/4/2015 10:58:50 AM
Keryx Biopharmaceuticals (KERX) Completes Transition Of CEO Role To Greg Madison 5/1/2015 7:31:07 AM